Fig. 5.

Overlap in achievement of WP-NRS 0/1, DLQI 0/1, and POEM 0–2 at week 16 for patients enrolled in the Measure Up 1 and Measure Up 2 studies. Data are reported as % (n). Percentages are calculated among patients who achieved at least one of the following endpoints at week 16: WP-NRS 0/1, DLQI 0/1, or POEM 0–2. Data from all treatment groups were combined. The analysis was based on observed cases, including only patients with non-missing data for all three outcome measures at week 16. DLQI Dermatology Life Quality Index, POEM Patient-Oriented Eczema Measure, WP-NRS Worst Pruritus Numerical Rating Scale